Effects of Lagenbone on Bone Mineral Density

Southern California University of Health Sciences

Status: Completed

Conditions: Osteoporosis

Treatments: Dietary Supplement: Lagenbone

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04557553

SUNT001

Details and patient eligibility

About

To study the effects of the herbal supplement Lagenbone on Bone Mineral Density

Full description

To study the effects of the herbal supplement Lagenbone on Bone Mineral Density. Lagenbone is a supplement based on the Chinese Herbal formula Gui Lu Er Xian Jiao.

Enrollment: 10 patients

Sex: All

Ages: 40 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis of osteoporosis
• Able to read and understand English
• Willing to receive routine DEXA scans and comply with supplement schedule

Exclusion criteria

• Pregnant, lactating, or having gestational diabetes
• Diagnosed with comorbid conditions that they are taking medication for e.g. Acid reflux, Hashimoto's/Grave's Disease, Endometriosis, prostate, breast, uterine cancer, kidney disease, fibroids, psychological disorders
• Use of any medication known to interfere with bone mineral density
• Are taking any new medications/supplements/treatments/therapeutic exercise within the last two months for osteoporosis or bone density
• Involved in health-related litigation, claims
• Missing baseline visits
• Vegan or vegetarian
• Diagnosed with Alzheimer's or demonstrating onset of dementia

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Lagenbone

Experimental group

Description:

Lagenbone 500mg capsules, 8 capsules by mouth every day for 12 months.

Treatment:

Dietary Supplement: Lagenbone